Dana-Farber Cancer Institute /ID# 230061

Boston, Massachusetts 02215

1 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia (CLL)

Studies at this site

• Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL) — Recruiting now